The American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the patterns of symptoms and severity of COVID-19 among patients with cancer, as well as, how COVID-19 is impacting the delivery of cancer care and patient outcomes.

ASCO will deliver periodic reports with key findings so that the oncology community has real-time information to help inform treatment approaches for patients with cancer who have a confirmed COVID-19 infection. The reports will allow practices to easily and confidentially share information on COVID-19 infections among their patients.

More Details

ASCO Registry FAQs

Enroll Your Practice

• Virtual program on treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) - multiple dates

• Expanded Access Navigator
• Test4TRK™: NTRK Sponsored Testing Program

Latest FDA Approvals

Package/Label Updates

Other Updates

https://www.asco.org/asco-coronavirus-information

COVID-19 Updates